NO902861D0 - Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav. - Google Patents

Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav.

Info

Publication number
NO902861D0
NO902861D0 NO902861A NO902861A NO902861D0 NO 902861 D0 NO902861 D0 NO 902861D0 NO 902861 A NO902861 A NO 902861A NO 902861 A NO902861 A NO 902861A NO 902861 D0 NO902861 D0 NO 902861D0
Authority
NO
Norway
Prior art keywords
naphythyloxypyridamines
naftylamino
procedures
preparing
related compounds
Prior art date
Application number
NO902861A
Other languages
English (en)
Other versions
NO902861L (no
Inventor
Richard Charles Effland
Joseph Thomas Klein
Gordon Edward Olsen
Larry Davis
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO902861D0 publication Critical patent/NO902861D0/no
Publication of NO902861L publication Critical patent/NO902861L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO90902861A 1989-06-28 1990-06-27 Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav. NO902861L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90/002767A US4931457B1 (en) 1989-06-28 1989-06-28 Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders

Publications (2)

Publication Number Publication Date
NO902861D0 true NO902861D0 (no) 1990-06-27
NO902861L NO902861L (no) 1991-01-02

Family

ID=23468431

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902861A NO902861L (no) 1989-06-28 1990-06-27 Naftylamino- og naftyloksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav.

Country Status (12)

Country Link
US (1) US4931457B1 (no)
EP (1) EP0405426A3 (no)
JP (1) JPH0338567A (no)
KR (1) KR910000647A (no)
AU (1) AU5784790A (no)
CA (1) CA2019624A1 (no)
FI (1) FI903214A7 (no)
IE (1) IE902330A1 (no)
IL (1) IL94876A0 (no)
NO (1) NO902861L (no)
PT (1) PT94502A (no)
ZA (1) ZA905001B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
TW200462B (no) * 1990-09-27 1993-02-21 Hoechst Roussel Pharma
US5581010A (en) * 1994-07-22 1996-12-03 Rockwell International Corporation Semi-organic crystals for nonlinear optical devices
RU2129832C1 (ru) * 1995-01-31 1999-05-10 Иркутский Государственный Медицинский Институт Способ диагностики периодов асептического воспаления кожи
DE19740785A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Arylsulfonamide und Analoga
EP0966436B1 (de) * 1997-02-21 2002-12-11 Bayer Aktiengesellschaft Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3118884A (en) * 1959-10-19 1964-01-21 Schering Corp Derivatives of 3-azaphenothiazine and 3-azaphenoxazine
US3495969A (en) * 1967-09-25 1970-02-17 Mobil Oil Corp Substituted nitropyridines as herbicides
US3576616A (en) * 1969-05-15 1971-04-27 Monsanto Co Herbicidal compositions and methods
US3721676A (en) * 1969-11-12 1973-03-20 Merck & Co Inc Certain 3-amino-2(1h)pyridones
EP0000816A1 (en) * 1977-08-06 1979-02-21 Beecham Group Plc Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
GB2073736B (en) * 1979-10-03 1984-02-01 Ici Ltd Process for preparing pyridinyloxyphenoxy compounds and derivatives thereof
US4521426A (en) * 1982-09-30 1985-06-04 Union Carbide Corporation Pesticidal bicyclooxyheterocyclyl aroyl ureas
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds

Also Published As

Publication number Publication date
FI903214A7 (fi) 1990-12-29
JPH0338567A (ja) 1991-02-19
FI903214A0 (fi) 1990-06-26
IE902330L (en) 1990-12-28
IE902330A1 (en) 1991-01-16
US4931457B1 (en) 1993-11-16
EP0405426A3 (en) 1992-05-13
CA2019624A1 (en) 1990-12-28
EP0405426A2 (en) 1991-01-02
NO902861L (no) 1991-01-02
ZA905001B (en) 1991-03-27
KR910000647A (ko) 1991-01-29
IL94876A0 (en) 1991-04-15
AU5784790A (en) 1991-01-03
US4931457A (en) 1990-06-05
PT94502A (pt) 1991-02-08

Similar Documents

Publication Publication Date Title
NO903656L (no) Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner.
NO903928L (no) Metallocenforbindelser og fremgangsmaate for deres fremstilling.
DK577084D0 (da) 2,2'iminobisethanol-derivater og fremgangsmaade til fremstilling deraf
NO891866L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO880434L (no) Bedoevelsesmiddel og fremgangsmaate for bruk derav.
DK581688D0 (da) L-tyrosinderivater og fremgangsmaade til fremstilling af samme
NO892494L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO882562D0 (no) Nye 2-guanidino-tiazol-forbindelser fremgangsmaate for fremstilling derav og anvendelse derav.
NO901832D0 (no) Fremgangsmaate for fremstilling av polyketon.
NO894103L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
FI906302L (fi) Belaeggningsfoerfarande.
IT1237508B (it) Procedimento per preparare n-fosfonometilglicina.
DK217388D0 (da) 1,3-dioxaner og fremgangsmaade til fremstilling deraf
DK103889A (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
NO911047L (no) Labdaner og fremgangsmaate for deres fremstilling.
NO900252D0 (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
NO902890D0 (no) Fenoksypyridinaminer og beslektede forbindelser og fremgangsmaate for fremstilling derav.
NO893963D0 (no) 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav.
NO903136D0 (no) Cefalosporinderivater og fremgangsmaate for fremstilling derav.
DK129689A (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
NO903196L (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
NO902346D0 (no) Organisk fosfitt og fremgangsmaate for dets fremstilling.
NO894763L (no) Benzensulfonamidderivater og fremgangsmaate for fremstilling derav.
IT1230097B (it) Procedimento per preparare perfluorosuccinilfluoruro.